Key terms
About BLUE
bluebird bio, Inc. is a clinical-stage biotechnology company, which engages in researching, developing and commercializing potentially transformative gene therapies for severe genetic diseases. It also offers ZYNTEGLO or beti-cel and SKYSONA or eli-cel gene therapies. The company was founded by Philippe Leboulch and Ronald C. Dorazio on April 16, 1992 and is headquartered in Somerville, MA.
Sector
Industry
Employees
Founded
Website
Key stock statistics
1-day range
52-week range
Market cap
P/E ratio
Next earnings date
Dividend yield
Ex-dividend date
Dividend pay date
Key terms
Ad Feedback
Smart score
Latest BLUE news
Apr 08
10:00pm ET
Analysts’ Opinions Are Mixed on These Healthcare Stocks: Bluebird Bio (BLUE), Sarepta Therapeutics (SRPT) and Jazz Pharmaceuticals (JAZZ)
Mar 30
3:48pm ET
Is Beam Therapeutics Stock (NASDAQ:BEAM) Too Late to the Game?
Mar 29
4:20am ET
Analysts Offer Insights on Healthcare Companies: Apellis Pharmaceuticals (APLS) and Bluebird Bio (BLUE)
Mar 29
3:08am ET
Bluebird Bio’s Hold Rating: Balancing Commercial Progress with Financial Restatements and Investor Concerns
Mar 28
5:35pm ET
bluebird bio, Inc. Class Action: Levi & Korsinsky LLP Reminds bluebird bio Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of May 28, 2024 – BLUE
Mar 27
7:29am ET
Bluebird Bio price target lowered to $4 from $5 at BofA
Mar 26
8:49pm ET
Bluebird Bio price target lowered to $3 from $4 at Wells Fargo
Mar 26
8:02pm ET
Analysts Offer Insights on Healthcare Companies: Johnson & Johnson (JNJ), Healthequity (HQY) and Bluebird Bio (BLUE)
Mar 26
7:50pm ET
Analysts’ Opinions Are Mixed on These Healthcare Stocks: Bluebird Bio (BLUE) and BeiGene (BGNE)
Mar 26
5:25pm ET
Hold Rating on Bluebird Bio Amidst Gradual Patient Starts and Funding Steps
Mar 26
8:05am ET
Options Volatility and Implied Earnings Moves Today, March 26, 2024
Mar 21
2:38am ET
Optimistic Outlook for Bluebird Bio: Buy Rating Affirmed on Extended Financial Runway and Profitability Prospects
Mar 19
8:56am ET
Bluebird Bio price target lowered to $1.68 from $3 at Wedbush
Mar 14
12:50pm ET
Cantor Fitzgerald biotech analysts hold an analyst/industry conference call
Mar 14
11:41am ET
Cantor Fitzgerald biotech analysts hold an analyst/industry conference call
Mar 11
8:15am ET
Bluebird Bio signs Medicaid outcomes-based agreement for Lyfgenia
Mar 01
1:20am ET
Strong Market Potential for Bluebird Bio’s Lyfgenia Backed by High Demand and Differentiation Factors
Feb 01
12:40am ET
Analysts Offer Insights on Healthcare Companies: Bluebird Bio (BLUE), Sarepta Therapeutics (SRPT) and Alcon (ALC)
Jan 11
1:31am ET
Market Perform Rating Maintained for Bluebird Bio Amidst New Therapy Launch and Financial Uncertainty
Jan 10
5:43am ET
Hold Rating on Bluebird Bio Amid Launch Optimism and Financial Prudence
Jan 09
4:55am ET
William Blair Reaffirms Their Hold Rating on Bluebird Bio (BLUE)
Yesterday
8:25pm ET
Levi & Korsinsky Notifies Shareholders of bluebird bio, Inc. (BLUE) of a Class Action Lawsuit and an Upcoming Deadline
Yesterday
7:20pm ET
ROSEN, A TRUSTED AND LEADING LAW FIRM, Encourages bluebird bio Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - BLUE
Yesterday
6:15pm ET
Shareholders that lost money on bluebird bio, Inc.(BLUE) Urged to Join Class Action – Contact Levi & Korsinsky to Learn More
Yesterday
6:15pm ET
Class Action Filed Against bluebird bio, Inc. (BLUE) Seeking Recovery for Investors - Contact Levi & Korsinsky
Yesterday
4:30pm ET
Shareholders that lost money on bluebird bio, Inc.(BLUE) Urged to Join Class Action - Contact Levi & Korsinsky to Learn More
Yesterday
1:30pm ET
Lost Money on bluebird bio, Inc.(BLUE)? Join Class Action Suit Seeking Recovery - Contact Levi & Korsinsky
Yesterday
1:30pm ET
Class Action Filed Against bluebird bio, Inc. (BLUE) Seeking Recovery for Investors - Contact Levi & Korsinsky
Yesterday
12:45pm ET
Shareholders that lost money on bluebird bio, Inc. (BLUE) should contact Levi & Korsinsky about pending Class Action - BLUE
Yesterday
12:31pm ET
SHAREHOLDER ACTION NOTICE: The Schall Law Firm Encourages Investors in bluebird bio, Inc. with Losses of $100,000 to Contact the Firm
Yesterday
8:35am ET
Shareholders of bluebird bio, Inc. Should Contact Levi & Korsinsky Before May 28, 2024 to Discuss Your Rights - BLUE
Yesterday
8:00am ET
SHAREHOLDER ACTION ALERT: The Schall Law Firm Encourages Investors in bluebird bio, Inc. with Losses of $100,000 to Contact the Firm
Apr 17
9:30pm ET
BLUE LAWSUIT ALERT: Levi & Korsinsky Notifies bluebird bio, Inc. Investors of a Class Action Lawsuit and Upcoming Deadline
Apr 17
8:15pm ET
Levi & Korsinsky Notifies Shareholders of bluebird bio, Inc.(BLUE) of a Class Action Lawsuit and an Upcoming Deadline
Apr 17
8:15pm ET
Contact Levi & Korsinsky by May 28, 2024 Deadline to Join Class Action Against bluebird bio, Inc.(BLUE)
Apr 17
7:15pm ET
BLUE INVESTOR NOTICE: ROSEN, LEADING INVESTOR COUNSEL, Encourages bluebird bio Inc. Investors to Inquire About Securities Class Action Investigation - BLUE
Apr 17
4:30pm ET
Levi & Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of May 28, 2024 in bluebird bio Lawsuit - BLUE
Apr 17
2:45pm ET
bluebird bio, Inc. Class Action: Levi & Korsinsky Reminds bluebird bio Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of May 28, 2024 - BLUE
Apr 17
1:30pm ET
May 28, 2024 Deadline: Contact Levi & Korsinsky to Join Class Action Suit Against BLUE
Apr 17
12:30pm ET
SHAREHOLDER ACTION REMINDER: The Schall Law Firm Encourages Investors in bluebird bio, Inc. with Losses of $100,000 to Contact the Firm
Apr 17
2:25am ET
Levi & Korsinsky Reminds bluebird bio Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of May 28, 2024 - BLUE
Apr 16
11:00pm ET
Shareholders that lost money on bluebird bio, Inc.(BLUE) should contact Levi & Korsinsky about pending Class Action - BLUE
Apr 16
10:30pm ET
SHAREHOLDER ACTION ALERT: The Schall Law Firm Encourages Investors in bluebird bio, Inc. with Losses of $100,000 to Contact the Firm
Apr 16
7:14pm ET
ROSEN, TOP RANKED NATIONAL INVESTOR ATTORNEYS, Encourages bluebird bio Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - BLUE
Apr 16
6:18pm ET
DEADLINE REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of bluebird bio
Apr 16
2:00pm ET
Levi & Korsinsky Reminds bluebird bio, Inc. Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of May 28, 2024 - BLUE
Apr 16
1:15pm ET
Investors who lost money on bluebird bio, Inc.(BLUE) should contact Levi & Korsinsky about pending Class Action - BLUE
Apr 15
7:13pm ET
ROSEN, A GLOBAL AND LEADING LAW FIRM, Encourages bluebird bio Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - BLUE
Apr 15
6:45pm ET
Class Action Filed Against bluebird bio, Inc. (BLUE) - May 28, 2024 Deadline to Join – Contact Levi & Korsinsky
Apr 15
1:45pm ET
Investors in bluebird bio, Inc. Should Contact Levi & Korsinsky Before May 28, 2024 to Discuss Your Rights - BLUE
Apr 15
1:00pm ET
SHAREHOLDER ACTION ALERT: The Schall Law Firm Encourages Investors in bluebird bio, Inc. with Losses of $100,000 to Contact the Firm
Apr 15
11:45am ET
Levi & Korsinsky Notifies Shareholders of bluebird bio, Inc.(BLUE) of a Class Action Lawsuit and an Upcoming Deadline
BLUE Financials
Key terms
Ad Feedback
BLUE Forecasts
analyst rating
- buy
- hold
- sell
1-year stock price forecast
BLUE Competitors
$ Market cap
P/E ratio
$ Price
1d change
52-week range
